West Virginia University Logo

Disease Site: Gynecologic Cancers

2 protocol(s) meet the specified criteria

  • 4010-01-001A Phase I Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors.
  • EAY131Molecular Analysis for Therapy Choice (MATCH)